These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9537580)

  • 21. A pathologic study of Hodgkin's disease in Korea and its association with Epstein-Barr virus infection.
    Huh J; Park C; Juhng S; Kim CE; Poppema S; Kim C
    Cancer; 1996 Mar; 77(5):949-55. PubMed ID: 8608489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mutations of the Epstein-Barr virus LMP1 gene mutations in Russian patients with lymphoid pathology and healthy individuals].
    Pavlish OA; Diduk SV; Smirnova KV; Shcherbak LN; Goncharova EV; Shalginskikh NA; Arkhipov VV; Kichigina MIu; Stepina VN; Belousova NV; Osmanov EA; Iakovleva LS; Gurtsevich VE
    Vopr Virusol; 2008; 53(1):10-6. PubMed ID: 18318128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Internal deletions of the latent membrane protein oncogenes of Epstein-Barr virus in Hodgkin's disease are almost identical with those of Asiatic nasopharyngeal carcinoma].
    Odermatt BF; Heitz PU; Bachmann E; Brousset P; Sandvej K; Knecht H
    Verh Dtsch Ges Pathol; 1994; 78():324-8. PubMed ID: 7534006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus in Hodgkin's disease: more than just an innocent bystander.
    Oudejans JJ; Jiwa NM; Meijer CJ
    J Pathol; 1997 Apr; 181(4):353-6. PubMed ID: 9196428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of HLA-A*02 antigen status in Hodgkin's disease and analysis of an HLA-A*02-restricted epitope of the Epstein-Barr virus LMP-2 protein.
    Bryden H; MacKenzie J; Andrew L; Alexander FE; Angus B; Krajewski AS; Armstrong AA; Gray D; Cartwright RA; Kane E; Wright DH; Taylor P; Jarrett RF
    Int J Cancer; 1997 Aug; 72(4):614-8. PubMed ID: 9259400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of interleukin-6 expression in Hodgkin and Reed-Sternberg cells by Epstein-Barr virus.
    Herbst H; Samol J; Foss HD; Raff T; Niedobitek G
    J Pathol; 1997 Jul; 182(3):299-306. PubMed ID: 9349232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus latent membrane protein-1 activates CD25 expression in lymphoma cells involving the NFkappaB pathway.
    Vockerodt M; Tesch H; Kube D
    Genes Immun; 2001 Dec; 2(8):433-41. PubMed ID: 11781710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of wild type and deleted latent membrane protein 1 (LMP1) of Epstein-Barr virus in clinical biopsy material.
    Nicholls J; Hahn P; Kremmer E; Fröhlich T; Arnold GJ; Sham J; Kwong D; Grässer FA
    J Virol Methods; 2004 Mar; 116(1):79-88. PubMed ID: 14715310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: high frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas.
    Sandvej K; Peh SC; Andresen BS; Pallesen G
    Blood; 1994 Dec; 84(12):4053-60. PubMed ID: 7994023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative analysis of oncogenic properties and nuclear factor-kappaB activity of latent membrane protein 1 natural variants from Hodgkin's lymphoma's Reed-Sternberg cells and normal B-lymphocytes.
    Faumont N; Chanut A; Benard A; Cogne N; Delsol G; Feuillard J; Meggetto F
    Haematologica; 2009 Mar; 94(3):355-63. PubMed ID: 19211641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease.
    Knecht H; Berger C; McQuain C; Rothenberger S; Bachmann E; Martin J; Esslinger C; Drexler HG; Cai YC; Quesenberry PJ; Odermatt BF
    Oncogene; 1999 Nov; 18(50):7161-7. PubMed ID: 10597317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic diversity of EBV-encoded LMP1 in the Swiss HIV Cohort Study and implication for NF-Κb activation.
    Zuercher E; Butticaz C; Wyniger J; Martinez R; Battegay M; Boffi El Amari E; Dang T; Egger JF; Fehr J; Mueller-Garamvögyi E; Parini A; Schaefer SC; Schoeni-Affolter F; Thurnheer C; Tinguely M; Telenti A; Rothenberger S;
    PLoS One; 2012; 7(2):e32168. PubMed ID: 22384168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of cytotoxic property in a variant of Epstein-Barr virus latent membrane protein-1 isolated from nasopharyngeal carcinoma.
    Nitta T; Chiba A; Yamamoto N; Yamaoka S
    Cell Signal; 2004 Sep; 16(9):1071-81. PubMed ID: 15212767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The NPC derived C15 LMP1 protein confers enhanced activation of NF-kappa B and induction of the EGFR in epithelial cells.
    Miller WE; Cheshire JL; Baldwin AS; Raab-Traub N
    Oncogene; 1998 Apr; 16(14):1869-77. PubMed ID: 9583684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Hodgkin's disease Reed-Sternberg cells and normal B-lymphocytes are infected by related Epstein-Barr virus strains.
    Faumont N; Trempat P; Brousset P; Delsol G; Meggetto F
    Virus Res; 2004 May; 101(2):163-73. PubMed ID: 15041184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein--Barr virus gene polymorphisms in Chinese Hodgkin's disease cases and healthy donors: identification of three distinct virus variants.
    Zhou XG; Sandvej K; Li PJ; Ji XL; Yan QH; Zhang XP; Da JP; Hamilton-Dutoit SJ
    J Gen Virol; 2001 May; 82(Pt 5):1157-1167. PubMed ID: 11297690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease.
    Glavina-Durdov M; Jakic-Razumovic J; Capkun V; Murray P
    Br J Cancer; 2001 May; 84(9):1227-34. PubMed ID: 11336475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
    Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.
    Larcher C; Bernhard D; Schaadt E; Adler B; Ausserlechner MJ; Mitterer M; Huemer HP
    Haematologica; 2003 Dec; 88(12):1324-35. PubMed ID: 14687985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of chemokines in Hodgkin's disease.
    Teruya-Feldstein J; Tosato G; Jaffe ES
    Leuk Lymphoma; 2000 Jul; 38(3-4):363-71. PubMed ID: 10830743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.